Literature DB >> 11874900

Effect of exogenous interleukin-18 (IL-18) and IL-12 in the course of Brucella abortus 2308 infection in mice.

Paolo Pasquali1, Rosanna Adone, Louis C Gasbarre, Claudia Pistoia, Franco Ciuchini.   

Abstract

In this study we demonstrated that combined inoculation of interleukin-12 (IL-12) and IL-18 reduced the number of bacteria in the spleens of mice infected with Brucella abortus 2308 and that the effect of the treatment was mediated by an increased capability of spleen cells to produce gamma interferon at the early phase of infection.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11874900      PMCID： PMC119949          DOI： 10.1128/cdli.9.2.491-492.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  14 in total

Review 1.  Regulation of interferon-gamma production by IL-12 and IL-18.

Authors:  H Okamura; S Kashiwamura; H Tsutsui; T Yoshimoto; K Nakanishi
Journal:  Curr Opin Immunol       Date:  1998-06       Impact factor: 7.486

2.  The adjuvant effect of a single dose of interleukin-12 on murine immune responses to live or killed Brucella abortus strain RB51.

Authors:  I K Lee; S C Olsen; M Kehrli; C A Bolin
Journal:  Can J Vet Res       Date:  1999-10       Impact factor: 1.310

3.  Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection.

Authors:  P Pasquali; R Adone; L C Gasbarre; C Pistoia; F Ciuchini
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages.

Authors:  S M Jones; A J Winter
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

Review 5.  Proinflammatory and immunoregulatory functions of interleukin-12.

Authors:  G Trinchieri
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

Review 6.  Interleukin-12 in infectious diseases.

Authors:  L Romani; P Puccetti; F Bistoni
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

7.  Cloning of a new cytokine that induces IFN-gamma production by T cells.

Authors:  H Okamura; H Tsutsi; T Komatsu; M Yutsudo; A Hakura; T Tanimoto; K Torigoe; T Okura; Y Nukada; K Hattori
Journal:  Nature       Date:  1995-11-02       Impact factor: 49.962

8.  Endogenous gamma interferon mediates resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Endogenous interleukin-12 is involved in resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice.

Authors:  M G Stevens; G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441
View more
  4 in total

1.  Role of caspase 1 in murine antibacterial host defenses and lethal endotoxemia.

Authors:  Vishwas D Joshi; Dhananjaya V Kalvakolanu; John R Hebel; Jeffrey D Hasday; Alan S Cross
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Brucella abortus RB51 induces protection in mice orally infected with the virulent strain B. abortus 2308.

Authors:  Paolo Pasquali; Adone Rosanna; Claudia Pistoia; Paola Petrucci; Franco Ciuchini
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Brucella Omp25 Upregulates miR-155, miR-21-5p, and miR-23b to Inhibit Interleukin-12 Production via Modulation of Programmed Death-1 Signaling in Human Monocyte/Macrophages.

Authors:  Beibei Cui; Wenli Liu; Xiaoya Wang; Yu Chen; Qian Du; Xiaomin Zhao; Hai Zhang; Shan-Lu Liu; Dewen Tong; Yong Huang
Journal:  Front Immunol       Date:  2017-06-26       Impact factor: 7.561

4.  MyD88-Dependent Glucose Restriction and Itaconate Production Control Brucella Infection.

Authors:  Carolyn A Lacey; Bárbara Ponzilacqua-Silva; Catherine A Chambers; Alexis S Dadelahi; Jerod A Skyberg
Journal:  Infect Immun       Date:  2021-06-14       Impact factor: 3.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.